REGENERON PHARMACEUTICALS, INC. (REGN) is a Health Care company in the Pharmaceutical Preparations industry (SEC CIK 0000872589). Annual revenue was $14.34B in FY2025, compared to $16.07B in FY2021. Net income in FY2025 was $4.50B (diluted EPS $41.48).
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $14.34B | $14.20B | $13.12B | $12.17B | $16.07B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $3.58B | $3.99B | $4.05B | $4.74B | $8.95B |
| Net Income | $4.50B | $4.41B | $3.95B | $4.34B | $8.08B |
| EPS (Diluted) | $41.48 | $38.34 | $34.77 | $38.22 | $71.97 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $40.56B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $4.98B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0000872589-26-000014 | Apr 29, 2026 | Apr 29, 2026 | Apr 29, 2026 10:50 UTC | EDGAR |
| 10-Q | 0000872589-26-000016 | Mar 31, 2026 | Apr 29, 2026 | Apr 29, 2026 10:54 UTC | EDGAR |
| 8-K | 0001104659-26-040661 | Apr 8, 2026 | Apr 8, 2026 | Apr 8, 2026 11:05 UTC | EDGAR |
| 10-K | 0000872589-26-000008 | Dec 31, 2025 | Feb 4, 2026 | Feb 4, 2026 14:08 UTC | EDGAR |
| 8-K | 0000872589-26-000004 | Jan 30, 2026 | Jan 30, 2026 | Jan 30, 2026 11:51 UTC | EDGAR |
| 8-K | 0001104659-26-002691 | Jan 12, 2026 | Jan 12, 2026 | Jan 12, 2026 11:48 UTC | EDGAR |
| 8-K | 0000872589-25-000026 | Oct 28, 2025 | Oct 28, 2025 | Oct 28, 2025 10:50 UTC | EDGAR |
| 10-Q | 0000872589-25-000028 | Sep 30, 2025 | Oct 28, 2025 | Oct 28, 2025 10:56 UTC | EDGAR |
Direct links to SEC EDGAR. REGN has additional filings available on the SEC site.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $37.76B |
| $33.08B |
| $29.21B |
| $25.43B |
| Total Liabilities | $9.30B | $8.41B | $7.11B | $6.55B | $6.67B |
|---|
| Stockholders' Equity | $0.03B | $29.35B | $25.97B | $22.66B | $18.77B |
|---|
| Cash & Equivalents | $3.12B | $2.49B | $2.73B | $3.12B | $2.90B |
|---|
| Total Debt | — | — | — | — | — |
|---|
| $4.42B |
| $4.59B |
| $5.01B |
| $7.08B |
| Capital Expenditures | — | — | — | — | — |
|---|
| Free Cash Flow | — | — | — | — | — |
|---|
| — |
| — |
| — |
| Operating Margin | 0.6% | 0.6% | 0.6% | 0.5% | 0.3% |
|---|
| Net Margin | 0.7% | 0.6% | 0.6% | 0.5% | 0.4% |
|---|
| Return on Equity | 13133.8% | 15.0% | 15.2% | 19.1% | 43.0% |
|---|
| Return on Assets | 11.1% | 11.7% | 12.0% | 14.9% | 31.7% |
|---|
| Debt / Equity | 0.30× | 0.29× | 0.27× | 0.29× | 0.36× |
|---|
